ArticleEmerging microbes & infections2026
Identification of Prohibitin (PHB) as an Entry Factor of Highly Pathogenic Coronaviruses Using Metabolic Glycoengineering and Photo-Crosslinking Techniques.
Article in Emerging microbes & infections, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Coronaviruses (CoVs) rely on host surface factors to mediate viral attachment and entry, yet conserved host cofactors shared across different CoVs remain poorly defined. Here, we established a host-factor capture platform based on metabolic glycoengineering and photo-crosslinking to identify host factors associated with CoV Spike proteins under near-physiological conditions. Using this approach, we identified prohibitin (PHB) as a candidate Spike-associated host factor shared by SARS-CoV, MERS-CoV, and SARS-CoV-2. Functional analyses showed that depletion of membrane-associated PHB decreased pseudovirus infection, whereas PHB reconstitution or overexpression enhanced susceptibility across multiple cell systems, including Huh7, BEAS-2B, Calu-3, and primary human airway epithelial cells (hAECs). In addition, antibody-mediated blockade of cell-surface PHB suppressed pseudovirus entry in both hAECs and human lung organoids. Immunohistochemical analyses further demonstrated PHB expression in normal human lung tissues. Mechanistically, recombinant PHB interacted with the Spike proteins of all three CoVs, and this association was supported by surface plasmon resonance and co-immunoprecipitation assays. Structural prediction combined with fragment-based alanine scanning identified residues 139-154 within the extracellular PHB domain as a critical region for efficient Spike association. Furthermore, PHB-associated pseudovirus entry was sensitive to lipid raft disruption, supporting a role for cholesterol-dependent membrane microdomains in this process. Together, these findings identify membrane-associated PHB as a conserved Spike-associated host factor linked to CoV entry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.